Si-Bone (SIBN) Short term Debt (2019 - 2022)
Si-Bone's (SIBN) quarterly Short term Debt came in at $1.5 million in Q3 2022, down 83.3% quarter-over-quarter from $8.7 million in Q1 2020.
Si-Bone (SIBN) Short term Debt (2019 - 2022) Analysis & Trends
Si-Bone's Short term Debt history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2022.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $1.5 million in Q3 2022; TTM through Sep 2022 was $1.5 million, a N/A change from a year earlier, with the FY2019 full-year figure at $4.4 million, changed N/A from the prior year.
- Short term Debt fell to $1.5 million in Q3 2022 per SIBN's latest filing, from $8.7 million in the prior quarter.
- Across five years, Short term Debt topped out at $8.7 million in Q1 2020 and bottomed at $1.5 million in Q3 2022.
- The 3-year median for Short term Debt is $4.4 million (2019), against an average of $4.8 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn |
| 10 | Si-Bone | 754.35 Mn | 609.67 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.46 Mn |
| Mar 31, 2020 | 8.73 Mn |
| Dec 31, 2019 | 4.36 Mn |